back to search abstracts online

Monday February 1,1999	Tuesday February 2, 1999	Wednesday February 3,1999	Thursday February 4,1999
Expanded Tropism of Human Immunodeficiency Virus by a Trans- Receptor Mechanism. Blocking of HIV-1 Co-receptor CCR5 in the hu-PBL-SCID Mouse Leads to a Co-receptor Switch. Natural Infection of a Red-Capped Mangabey with a Homozygous CCR5 Defect (d24) by a CCR2b-Tropic Simian Immunodeficiency Virus. Lack of Fitness of Protease Inhibitor-Resistant HIV-1 In Vivo. Discrimination Between Active and Inducible Viral RNA Transcription in HIV-1 Infected Subjects Regardless of Effective Antiretroviral Therapy. Residual HIV RNA and DNA in lymph node and HIV RNA in genital secretions and in CSF after two years of suppression of viremia in the Merck 035 cohort. HIV-1 Reservoirs Exist in the Semen of Men Receiving Highly Active Anti-Retroviral Therapy (HAART). Evidence for HIV-1 Latent Infection in Exposed Seronegative Individuals. Refined Estimates for HIV-1 Clearance Rate and Intracellular Delay. Rapid Clearance of HIV and Hepatitis C Virus (HCV) Particles Defined by Perturbing the Dynamic Equilibrium with Plasma Apheresis. Antiviral Activity and Resistance Profile of AG1776, A Novel Inhibitor of HIV-1 Protease. Antiviral Activity and Resistance Profile of AG1549, A Novel HIV-1 Nonnucleoside Reverse Transcriptase Inhibitor. DMP 961 and DMP 963: 2nd Generation Non-Nucleoside Reverse Transcriptase Inhibitors Active Against The RT K103N Mutant. A multiple regression model predicting response to combination therapy from baseline sequence data identifies amino acid sites not previously associated with resistance ABT-378/ritonavir Therapy in Antiretroviral-Naive HIV-I infected Patients for 24 Weeks. A Phase I/II Randomized, Controlled Study of FTC Versus 3TC in HIV-Infected Patients. A Phase I Gene Therapy Trial of Autologous CD34+ Cells Transduced With An Anti-HIV Ribozyme. The Atlantic Study: A Randomised Open-Label Study Comparing Two Protease Inhibitors (PI)-Sparing Antiretroviral Strategies Versus A Standard PI-Containing Regimen. Ziagen (Abacavir, ABC, 1592) Combined with 3TC & ZDV is Highly Effective and Durable Through 48 Weeks in HIV-1 Infected Antiretroviral-Therapy-Naive Subjects (CNAA3003). Ziagen/Combivir is Equivalent to Indinavir/Combivir in Antiretroviral Therapy (ART) Naive Adults at 24 weeks (CNA3005). Direct Evidence for de Novo T Cell Generation in Adults Is Provided by the Presence of T Cell Receptor DNA Excision Circles in Peripheral Blood Lymphocytes. T Cell Renewal Impaired in HIV-1 Infected Individuals Effect of Combination Antiretroviral Therapy on HIV-1-specific Cellular Immunity in Acute HIV-1 Infection Influence of Highly Active Antiretroviral Therapy (HAART) on CD8 T Cell Oligoclonality in HIV Infected Children A reevaluation of HIV-1 specific CTL precursor frequencies during acute HIV-1 infection. In Vivo Migration and Antiviral Activity of Transferred HIV-1-Specific Cytotoxic T Cells. Quantitative Analysis of HIV-Specific CD4+ Memory T Cells by Flow Cytometry. Differential Infection of CD45RA- and CD45RO+ CD4 T Cells by Syncytium Inducing (SI) and Non-Syncytium Inducing (NSI) HIV-1 Variants Cytokine and Chemokine Levels in HIV-1 Positive Patients Treated with Anti-CD3 Monoclonal Antibody (OKT3) and Recombinant IL-2. Influences on the CD4+ lymphoproliferative response in HIV-1 infection Longitudinal Analysis of CTL Precursor Frequency in Rhesus Macaques Immunized with Live Attenuated SIVmac239 Dnef and Challenged with Pathogenic SIVmac251 Analysis of Immune Selection of HIV-1 by CTL in a Cohort of HIV+ Patients. HIV-specific T Cell Gene Therapy in Subjects with Undetectable Viremia on HAART. Rantes and IFN b as Immune Mediators to Enhance Efficiency of Anti-HIV Specific Cytotoxic T Cells. CD8+ Lymphocytes from HCV/HBV Patients Are Able to Inhibit HIV Replication. Effect of passive infusion of SIV immune IgG into infected monkeys with limited endogenous anti-SIV responses. A Rapid Assay for Determination of the Neutralization of Multiple Primary Isolates of HIV-1 by Patient Sera. Probing of Epitopes Associated with HIV-1 Primary Virus Cross-Reactive Neutralizing Antibody (NA) Response. The Protection of Cynomolgus Monkeys Vaccinated with a D-Nef Live Attenuated SIV Is Maintained after Multiple Challenges with SIV and SHIV. Use of Mutant SIV DNA Immunization to Mimic Attenuated Virus Vaccines. Multi-Component DNA Immunization Provides Significant Immunity Against Immunodeficiency Virus Challenge. In Vitro and In Vivo Characterization of Primate Lentiviral Virions Inactivated by Targeting Nucleocapsid Protein Zinc Fingers. Phase I Study of the Safety and Immunogenicity of an ALVAC Vaccine in Children Born to HIV Infected Mothers: Preliminary Results. Induction of Cellular Immune Responses in HIV-1 Seronegative Volunteers with a DNA Vaccine Induction of In Vitro Resistance to R4 and R5 HIV-1 by Vaccination with ALVAC vCP300 Canarypox Vector containing env, gag, pol, and nef Gene Segments The Impact of Canary Pox Infection on Dendritic Cell Maturation Immunochemical analysis of soluble oligomeric envelope constructs from SF162, a primary HIV-1 isolate. Antigenicity and Immunogenicity of HIV-1 Envelope Glycoproteins Derived Either from Primary Isolates or T-Cell Line Adapted Strains. Prospective Identification of MHC Ligands and CTL Epitopes from HIV Proteins using Bioinformatics. Selection of Antigenic and Immunogenic Mimics of HIV-1 by Screening Random Peptide Libraries with HIV-1 Positive Sera. Correlation of de novo T cell production, thymic mass and peripheral blood immunophenotyping in HIV-1-infected individuals. Viral and Immunologic Examination of HIV-1-infected Persistently Seronegative (HIPS) Persons HIV-1 Infection Perturbs DNA Content of Peripheral Blood Mononuclear Cells: Effects of Antiviral Therapy. Productive HIV Infection in Double Negative (DN) T Cells Obtained ex vivo. Genetic Manipulation of Primary Human Lymphocytes Using an HIV-1 Derived Vector System: Requirements For Transduction of Resting T Cells. Expansion of T Lymphocytes from Cynomolgus Monkeys by CD3/CD28 Costimulation: a New Tool for Immunotherapy and Vaccine Applications. Tetanus Immunity in a Group of Children With Stable HIV Infection. In vitro HIV-1 Expression is enhanced by Neisseria gonorrhoeae and/or Associated Inflammatory Neutrophils CD8+ T cell apoptosis in HIV infected people results from costimulatory interactions with monocytes. SIVmac239 nef is Sufficient for Induction of Disease in Transgenic Mice. HIV-1 VIRAL LOADS AND CD4 LEVELS IN TREATED AND UNTREATED ADOLESCENTS. Perforin is not co-expressed with Granzyme A within Cytotoxic Granules in CD8 T-lymphocytes Present in Lymphoid Tissue during HIV-1 Infection. HIV-INFECTED LANGERHANS CELLS TRANSMIT VIRUS TO LYMPHOID TISSUE IN A NOVEL MODEL OF PRIMARY HIV INFECTION. Immunological Changes in Sooty Mangabeys Monkeys Naturally Infected with SIV. Mucosal Mononuclear Cells (MMCs) are More Infectable with HIV in vitro than Peripheral Blood Mononuclear Cells (PBMCs) CD4 T Lymphocytes That Coexpress CD45RO and CD45RA are the Primary Target Cells for Infection by HIV-1. Highly activated, mucosal, "memory" CD4+ T cells are the initial target for SIV infection and elimination in vivo. Primary Macrophage Cell Cultures Infected By HIV-1 Produce Highly Infectious Virus For Several Months. Correlation between HIV Viral Load and Coreceptor and Adhesion Molecule Phenotype in Neutrophils, Monocytes and Lymphocytes. Strong Association Between Failure of T-cell Homeostasis and the Syncytium-Inducing Phenotype Among HIV-1 Infected Men Developing AIDS in the Amsterdam Cohort Study. Accelerated Changes in T Cell Differentiation and Activation Associated with T Cell Homeostasis Failure and Emergence of X4 Variants of HIV-1. Distinct HIV-1 Strains in the Bone Marrow are Associated with the Development of Thrombocytopenia. Bone Marrow Microaggregate Culture: a Novel Method for Studying Viral -Induced Mechanisms of Hematosuppression. Helminthic Infections and Pathogenesis of AIDS Pathogenesis of SIV Infection of Neonatal Rhesus Macaques The Characterization of Four Novel SIV Strains from Cameroon: Implications for Primate Lentivirus Diversity. The rooted position of subtype G among the HIV-1 group M viruses and evidence for A/G recombination to overcome fitness loss. Genotypic and Phenotypic Characteristics of 6 HIV-1 Subtype A Virus Transmitted from Mother to Child. On The Functional Role Of HIV-1 p6Gag. Differential Inhibition of HIV-1 Gag-Pol Processing by Protease Inhibitors in Primary versus Transformed Cells. HIV-1 Virions Produced from Replicating Peripheral Blood Lymphocytes are More Infectious than those from Non-Proliferating Macrophages Due to Higher Levels of Intravirion Reverse Transcripts: Implications for Pathogenesis and Transmission. Strain Dependent HIV-1 Infection in Quiescent T Cells. Characterization of a soluble HIV-suppressive activity from enriched CD14 cultures The Channel-Forming Bacterial Toxin Aerolysin Neutralizes Human Immunodeficiency Virus Type 1 Consistent Viral Evolutionary Trends, X4 Viruses, and T Cell Dysregulation in the Progression of HIV-1 Infection to AIDS Dynamics of HIV Replication in T Lymphocytes. Role of the Leukocyte Function Antigen-1 Conformational State in the Process of HIV-1-Mediate Syncytium Formation and Virus Infection. Characterization of a Putative Protein Tyrosine Phosphorylation Site in the Cytoplasmic Domain of HIV-1 gp41. Neutralization of HIV-1 by Antibody to gp120 is Determined Primarily by Occupancy of Sites on the Virion Irrespective of Epitope Specificity. Human Immunodeficiency Virus Type-1 Recombination in vivo Associated with Selective Advantage for Fitness. Lack of detection of HIV-infected PBMCs despite positive plasma viremia in a subgroup of asymptomatic long-term non progressors. How Much Adherence is Enough? A Prospective Study of Adherence to Protease Inhibitor Therapy Using MEMSCaps Spontaneous Adherence (ADH) Audits (SAA) Predict Viral Suppression in the REACH Cohort. Self-reported Adherence to HAART and Correlation with HIV RNA: Initial Results with the Patient Medication Adherence Questionnaire Self-Reported Adherence to Protease Inhibitors Substantially Overestimates an Objective Measure. Adherence to Protease Inhibitor Therapy and Viral Load. Providers' Estimates of Adherence Overestimate Reports from Medication Event Monitoring System (MEMS) for Patients on Protease Inhibitors (PIs). Patient Characteristics and Attitudes associated with Antiretroviral (AR) Adherence. Reliability, Validity, and Usefulness of Touch-Screen Administration of QOL and Adherence Instruments in an Outpatient Clinic. Quality of Life in Prolonged Induction- versus Maintenance Therapy. Impact of Indinavir with Zidovudine and Lamivudine on Quality of Life for HIV Patients with <= 200 CD4 in ACTG 320 Health Care Costs for 1995-1998 in AIDS. Economic Evaluation of Triple ART with Indinavir or Abacavir and ZDV+3TC Compared to Dual Therapy ZDV+3TC. How Well Are We Doing in Adopting HIV Treatment Guidelines? Who Receives Highly Active Antiretroviral Therapy (HAART)? Data From a Nationally Representative Sample. Insurance and race predict access to HIV protease inhibitors HAART failure in the Inner-City The Relationship Between Literacy, Race, and Adherence to Potent Anti-Retroviral Therapies. Genotypic Correlates of In Vivo Resistance to Efavirenz In Vitro NNRTI Resistance of Recombinant HIV Carrying Mutations Observed in Efavirenz Treatment Failures Delavirdine Resistant Clinical Isolates Remained Susceptible to PNU142721 and DMP266 HIV Genotypes of Treatment-Naive Patients Receiving Adefovir Dipivoxil in a Highly Active Antiretroviral Therapy Regimen. The Multiple Nucleoside Analogue Resistance Mutations Confer Cross-Resistance to Abacavir. Genotype and Phenotype of HIV-1 in ART Experienced Adults Prior and Following Therapy with Ziagen (Abacavir, ABC) added to Stable Background Therapy (ABC+SBG) HIV-1 Genotype and Viral Response to Ziagen (Abacavir, ABC) + Protease Inhibitors (PI) in ART Naive Adults. Mutations in the Reverse Transcriptase Genome of HIV-1 Isolates Derived from Subjects Treated with Didanosine and Stavudine in Combination. Multiple Pathways to Resistance to ABT-378 Observed by In vitro Selection. HIV Drug Resistance Analysis during Clinical Studies with the Protease Inhibitor Amprenavir. Analysis of HIV Phenotypic Cross-Resistance to Protease Inhibitors in Patients Failing on Combination Therapies. Characterization of HIV-1 in Patients Following Long-Term RTV-SQV Therapy. Multidrug-Resistance Mutations to Dideoxynucleoside (ddN) Analogues Can Occur in Patients With Classical AZT Resistance Mutations. Evolutionary and Phenotypic Analysis of Multidrug-resistant HIV-1 Strains with Combinations of Insertions between Codons 68 and 69 and Amino Acid Changes in Reverse Transcriptase The RT 69(S) Insertion is Observed in NRTI Experienced HIV-1 Positive Subjects with Diverse Treatment Histories. Adefovir and PMPA are Active In Vitro Against HIV from Patients with Multiple Patterns of Nucleoside Resistance Mutations and the Lamivudine-Associated M184V RT Mutation. Prevalence of Drug Resistance Mutations Over Time in Naive HIV+ Subjects Living in Spain. A New Point Mutation in HIV-1 RT Confers Resistance to 3TC in vitro. Evolutionary Hotspot Around RT Codon 215 Evolves During Zidovudine Exposure. Impact of HIV gag p7/p1 and p1/p6 Cleavage Site Mutations on CD4 Evolution. T215Y/F mutation associated with zidovudine (ZDV) resistance leads to poor response to ZDV+ddI or ZDV+ddI+NVP: ACTG244/RV79. Baseline Resistance and Virological Response to Mega-HAART Salvage Therapies Baseline (BL) HIV-1 Protease (PR) and Reverse Transcriptase (RT) Genotype as a Predictor of Response to ZDV+3TC+Indinavir (IDV). Response to Combivir^{R} and Abacavir Given BID to Nucleoside Experienced Patients Is Not Affected By the Presence Of the M184V Mutation. HIV-1 Baseline Genotype/Phenotype and Virological Response Following Salvage Therapy with Ziagen (Abacavir, ABC), Amprenavir (APV), and Sustiva(TM) (Efavirenz, EFV). Analysis of Possible Predictors of Response to Abacavir (ABC) in Antiretroviral-Experienced Adults; Comparison of Viral Genotype, Viral Phenotype and Patient Treatment History. Treatment of Patients (pts.) who Have Virus with Mutations Suggesting Pan-Protease and -Reverse Transcriptase (RT) Drug Resistance. Can Baseline Genotype Predict Response to Salvage Therapy With Nelfinavir? Response to Therapy with Adefovir Dipivoxil is Durable for 48 Weeks and Correlates with Baseline HIV Genotype and In Vitro Susceptibility to Adefovir. Reverse Transcriptase Genotype After Multiple, Sequential Nucleoside Analog Drugs and the Response to HAART in ACTG 364. The Utility of HIV-1 Pol Gene Sequencing in Virological Management of Drug Naive and Experienced Patients Resistance Mutations as Predictor of Response to Salvage Therapy Rapid Phenotypic Assay for Detecting Multidrug Resistance of HIV-1 to Nucleoside Analogs. Resistance Genotyping of Subtypes A-F of HIV-1: Comparison between ABI and Affymetrix HIV-PRT Assays. GENETIC VARIABILITY IN THE VICINITY OF CODONS 41,70,184 AND 215 OF HIV-1 REVERSE TRANSCRIPTASE: IMPLICATIONS FOR THE DETECTION OF RESISTANCE-ASSOCIATED MUTATIONS BY LINE PROBE HIV-1 RT ASSAY. Recovery and Sequence Analysis of HIV RNA from Plasma Samples with Low HIV RNA Levels. Comparison of Copy Numbers Generated by 3 Commercial Highly Sensitive HIV Viral Load Measurement Systems. Evaluation of the New Quantiplex 3.0 HIV bDNA Assay (Q3): A Comparison with the Quantiplex 2.0 (Q2). Evaluation of Quantiplex(TM) 3.0 Assay. An Ultrasensitive NucliSens^{R} HIV-1 QT Procedure Is Able to Reliably Detect HIV Plasma Viral Loads down to 10 copies/ml. Comparison of Ultrasensitive Assays for Quantitation of HIV RNA in Plasma Samples. Sensitivity, Specificity, Linear Range and Quantification Evaluation of the Digene Hybrid Capture(r) II HIV RNA v1.0 Test with an Improved Plasma Specimen Preparation Method. Robustness of the Gen-Probe HIV-1 Viral Load Assay in the Presence of Potential Interferents. Automated Nucleic Acid Purification For Viral Load And Sequencing Using The NucliSens(TM) Extractor Virus Evolution in Patients on Active Antiretroviral Therapy with Sustained Undetectable Plasma HIV-1 RNA by Ultrasensitive RT-PCR Assay. HIV-1 RNA Transcription in Blood Cells of Patients with Undetectable Plasma Viral Loads. The use of real-time PCR to quantify HIV unspliced (US) mRNA in patients on effective antiretroviral therapy. The Accumulation of Tat-Restricted Latently Infected Cells following Highly Active Antiretroviral Therapy. A New Steady State of HIV Infection After HARRT Stability of HIV vDNA in peripheral blood and lymph node cells after HAART. Genetic Stability of the Latent HIV Reservoir in Memory CD4 T Cells During Suppressive Therapy. HIV-1 is Detectable in Mucosal Biopsies in Patients with Undetectable Plasma Viral Loads Sampling Lymphoid Tissue Cells by Ultrasound-guided Fine Needle Aspiration (USGNA) of Lymph Nodes in HIV-infected Patients. Study of Cell-associated HIV-1 Using a Quantitative CD4 Lymphocyte Outgrowth Assay. In Vitro Reactivation of HIV-1 in Latently Infected, Resting CD4+ T Cells by Allogeneic Stimulation In Vitro Reactivation of HIV-1 from Latently Infected, Resting CD4+ T Cells upon Stimulation with Microbial Co-Infections Predictive Value of Response at 12 and 24 Weeks for Durability of Response in a Study of the Soft Gelatin Capsule Formulation of Saquinavir (SQV-SGC) plus 2 Nucleosides in Treatment-Naive HIV-1-Positive Patients Initial HIV clearance rates do not predict long-term antiviral activity for Ritonavir-Saquinavir (R-S) combination therapy in HIV-protease inhibitor-naive patients Predictors of Viral Rebound 500 copies/mL after Initial Suppression by =3-Drug Therapy in 755 Clinic Patients. Immunologic Course of Antiretroviral Treated HIV-infected Patients with a Plateau Response to Therapy. Clinical Outcomes of Patients Under HAART With Discordant Response to CD4 and Viral Load at 6 Months. DETECTION OF HIV RNA IN PLASMA <400 COPIES/ML ASSOCIATED WITH VIROLOGIC REBOUND. Predictors of Virologic Response and Subsequent Failure to Five Different Initial Protease Inhibitor (PI) Treatment Regimens. The Magnitude of PVL Increase Does Not Predict Treatment Failure in INCAS and AVANTI Studies Initial Viral Load is Negatively Correlated with Rapid HIV Decline during HAART and Positively Correlated with HIV Rebound at its Interruption. Clinical relevance of undetectable HIV RNA levels measured by the ultrasensitive bDNA technology 3.0 The Impact of Ultrasensitive HIV-1 RT PCR Assay on Clinical Decision Making. Preliminary Evaluation of HIV-1 DNA Proviral Quantification Assays. HIV non-integrated DNA in the management of patients in antiretroviral combined therapy Diagnosis of Acute HIV Infection Using p24 Antigen and HIV-1 RNA Assays. Pitfalls of HIV RNA Testing in the San Francisco Post-Exposure Prevention (PEP) Project. Diagnosis and Monitoring of Pediatric HIV Infection: Prospective Comparison of RNA and Heat-Denatured p24 Antigen Early Diagnosis and Viral Dynamics in HIV-1 Infected Infants in Thailand Using RNA and DNA PCR Assays Sensitive to Non-B Subtypes Analysis of PCR Products from Replicate Amplification Reactions Facilitates Detection of HIV-1 Dual Infection. Comparison of Plasma HIV-1 RNA Quantification Assays in a Cross-Sectional Study Involving Individuals Believed to have been Infected in Africa and Western Europe. A Direct Effect of HIV Protease Inhibitors on Candida albicans: Prevention of Oral Candidiasis through Inhibition of Fungal Proteinase Continuous Improvement of Oral Candida Colonization and Skin Test Reactivity After One Year of Treatment with Protease Inhibitors. Evolution of fluconazole susceptibility among Candida isolates. The Molecular Epidemiology of Fluconazole Refractory Oral Candidiasis. Effect of CD40L on the Course of Histoplasmosis in CD4-Depleted Mice: a Model Resembling AIDS. Prevalence of Unrecognized Hepatitis B and C Infections in AIDS Patients with Abnormal Liver Function Tests. Liver Fibrosis Progression in Patients with Hepatitis C and HIV Infection. Histological Damage of Hepatitis C virus in HIV Infected Patients. A Case Control Study. Changes in HCV Viral Load in HIV Patients During HAART Therapy and After Therapy Failure. HAART Does Not Modify HCV Replication in HIV-HCV co-infected Patients. Carrying of GBV-C/Hepatitis G virus (HGV) RNA is associated with a more favorable immunological, virological and clinical progression of human immunodeficiency virus (HIV) disease in coinfected individuals. Hepatitis A Immunization in HIV-Infection. Prevalence of Hepatitis B Virus (HBV) resistance to Lamivudine in HIV-infected patients. Risk Factors For Human Herpes Virus-8 Seroprevalence in a Cohort of HIV Seronegative MSM. Concurrent Epidemics of HHV-8 and HIV-1 in Homosexual Men Do Homosexual Men Have a Higher Risk of KS Compared with Other HIV-HHV-8 Coinfected Individuals? HHV-8 Seroprevalence in an Injecting Drug User Cohort Coinfection of HIV and HHV-8: Seroepidemiology and Influence on the Course of HIV-Disease Longitudinal Study of Human Herpesvirus 8 in Patients with HIV Infection. Quantitation of HHV-8 Viral Load by PCR. Activity of Taxotere as Therapy for Pretreated HIV-Associated Kaposi's Sarcoma. An ANRS Trial. Pharmacokinetics with Protease Inhibitors. Topical Alitretinoin Gel as Treatment for Cutaneous Lesions of Patients with AIDS-Related Kaposi's Sarcoma: Results of Two Multicenter, Double-Blind, Vehicle-Controlled Trials. Evidence of immune reconstitution and HIV control following EPOCH chemotherapy (CT) for HIV-related lymphomas (HIV-NHL). Phenotypical And Histological Patterns Of Lymphomas In HIV-Patients Before And After HAART. The Epstein-Barr Virus BALF1 Gene Encodes a Viral Bcl-2 Homlog That Heterodimerizes with Bax and Bak. Multicentric Castleman's disease (MCD) in HIV infection Therapy and HHV8 viral load HIV-1 Transmission by a Needle-stick Injury Despite Rapid Initiation of Four-Drug Postexposure Prophylaxis. National Post-Exposure Prophylaxis Hotline (PEPline) for Health Care Workers: Exposure Characteristics and Treatment Recommendations. Antiretroviral post-exposure Prophylaxis. PRACTICES IN CONNECTION WITH OCCUPATIONAL EXPOSURE (OE) IN FRENCH NURSES. Utilization and Adherence of a Population-Based Post-Exposure Prophylaxis Program. Contrasting Non-Occupational From Occupational Exposures: Initial Findings From the San Francisco HIV Post-Exposure Prevention (PEP) Project. env and pol Polymorphisms in US Blood Donors with Recently Acquired HIV-1 Infections. Prevalence of Protease Inhibitor and Reverse Transcriptase Inhibitor Resistance Mutations in Recent HIV-1 Seroconverters in Seattle. Primary Antiretroviral Resistance in Recently Infected Injection Drug Users and in Drug Naive Individuals. Heterosexual Transmission of NNRTI-Resistant HIV-1. Seminal HIV-1 Culture Positivity Does Not Correlate with Viral Load. AZT & 3TC Affect Excretion of HIV in Semen: Measurement of Antiviral Drug Concentration in Blood and Seminal Plasma. The Effects of Amprenavir (APV) Alone or in Combination with ZDV/3TC, on HIV-1 Levels in Semen: A substudy of ACTG 347 Variation in Genital Tract Shedding of HIV RNA with the Menstrual Cycle. Correlations of HIV-1 Viral Loads in Plasma and Female Genital Tract Secretions with Systemic and Mucosal Immune Responses Dynamics of HIV-1 Suppression in the Genital Tract of Antiretroviral Naive HIV(+) Women Starting Highly Active Antiretroviral Therapy (HAART) Productive Infection of Human Epithelial cells by Cell-free HIV-1 Viruses - Implications to Possible Mechanisms of Sexual Transmission. New York State Comprehensive Newborn HIV Screening Program: the first eleven months On the Verge of Elimination of Perinatally Acquired HIV/AIDS? Updated Trends in HIV/AIDS in the United States Absence of Expression of the Chemokine Receptors CCR5 and CXCR4 on Human Placental Term Trophoblasts. CCR2B-641 chemokine receptor allele does not prevent mother-to-child HIV-1 transmission or disease progression in infected children. Mother-to Child Transmission of HIV-1: Evaluation of HIV-1 Coreceptor Usage Evidence for Transmission of Dual-Tropic HIV-1 from Mother to Child and Reversion to Macrophage Tropism with Age? HIV Infection of Human Placental Cord Blood CD34+ Stem Cells and Their Progeny. HIV RNA in Maternal and Cord Plasma. Evidence for in utero, Prenatal Transmission of Subtype C HIV-1 Infection in Zimbabwe. Maternal HIV-1 RNA and V3 Antibodies Predict Risks for Vertical Transmission and Mortality In Subtype C Virus Infection. Dual Infection with Subtype A and D HIV-1 in a Ugandan Mother-Infant Pair. The Relationship of Placental HIV RNA and Maternal Antiretroviral Therapy on Perinatal Transmission. Zidovudine Genotypic Resistance in HIV-1 Infected Newborns in the French HIV-1 Perinatal Cohort Study. Evaluation of Failure of ZDV in Preventing Perinatal HIV Transmission 3-Color Flow Cytometric Markers of Lymphocyte Activation and Memory in Perinatal HIV Transmission and Infant Infection. SAFETY, TOLERABILITY AND EFFICACY OF RITONAVIR IN THE PREVENTION OF VERTICAL TRANSMISSION.

© 6th Conference on Retroviruses and Opportunistic Infections,
Foundation for Retrovirology and Human Health

This site designed and maintained by:
© Medical Consumer Media. All Rights Reserved.
For inquiries, contact: retroinfo@medcm.com

The broadcasts of selected invited sessions from the 6th Conference on Retroviruses and Opportunistic Infections are for individual, non-commercial use only. No portion of this site (including speakers' audiotrack, slides, and abstracts) may be copied, reproduced, or rebroadcast without the express advanced written permission of the speaker(s) and the Conference Secretariat.